BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Deibert P, Lazaro A, Stankovic Z, Schaffner D, Rössle M, Kreisel W. Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up. World J Gastroenterol 2018; 24(3): 438-444 [PMID: 29391766 DOI: 10.3748/wjg.v24.i3.438]
URL: https://www.wjgnet.com/1007-9327/full/v24/i3/438.htm
Number Citing Articles
1
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionInternational Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
2
Wolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, Markus Grosse Perdekamp, Annette Schmitt-Graeff, Peter Deibert. Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic ImplicationsInternational Journal of Molecular Sciences 2021; 22(19): 10372 doi: 10.3390/ijms221910372
3
Frank E. Uschner, Kathleen Glückert, Rafael Paternostro, Thorsten Gnad, Robert Schierwagen, Mattias Mandorfer, Fernando Magdaleno, Cristina Ortiz, Katharina Schwarzkopf, Patrick S. Kamath, Carlo Alessandria, Christoph Boesecke, Alexander Pfeifer, Thomas Reiberger, Wolfgang Kreisel, Tilman Sauerbruch, Arnulf Ferlitsch, Jonel Trebicka, Sabine Klein. Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunctionLiver International 2020; 40(9): 2228 doi: 10.1111/liv.14586
4
Hui Li. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinomaDigestive and Liver Disease 2022; 54(5): 598 doi: 10.1016/j.dld.2021.07.006
5
Felix Abayomi Dada, Sunday Idowu Oyeleye, Stephen Adeniyi Adefegha, Ganiyu Oboh. Extracts from Almond ( Terminalia catappa ) leaf and stem bark mitigate the activities of crucial enzymes and oxidative stress associated with hypertension in cyclosporine A‐stressed rats Journal of Food Biochemistry 2021; 45(3) doi: 10.1111/jfbc.13435
6
Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour. Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indicationsFundamental & Clinical Pharmacology 2021; 35(2): 235 doi: 10.1111/fcp.12633
7
Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Choudhary, Vijayaraghavan Rajan, Vinod Arora, Ankit Bhardwaj, Guresh Kumar, Manoj Kumar, Shiv K. Sarin. Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trialHepatology International 2021;  doi: 10.1007/s12072-021-10264-w
8
Rakesh Kumar Jagdish. Sexual dysfunctions and their treatment in liver diseasesWorld Journal of Hepatology 2022; 14(8): 1530-1540 doi: 10.4254/wjh.v14.i8.1530
9
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, Jordi Gracia-Sancho. Novel therapeutics for portal hypertension and fibrosis in chronic liver diseasePharmacology & Therapeutics 2020; 215: 107626 doi: 10.1016/j.pharmthera.2020.107626
10
Sasan Sakiani, Theo Heller, Christopher Koh. Current and investigational drugs in early clinical development for portal hypertensionFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.974182
11
Marina Vilaseca, Sergi Guixé-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho. Advances in therapeutic options for portal hypertensionTherapeutic Advances in Gastroenterology 2018; 11: 175628481881129 doi: 10.1177/1756284818811294